# A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study

> **NCT03936192** · PHASE3 · WITHDRAWN · sponsor: **Eurofarma Laboratorios S.A.**

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** glucosamine sulphate 1500mg and meloxicam 15mg
- **DRUG:** Glucosamine sulfate 1500mg and chondroitin sulfate 1200mg
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03936192
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936192, "A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03936192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*